Alza Resubmits Ionsys NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Alza has resubmitted an NDA for its patient-controlled transdermal analgesic Ionsys (fentanyl), the Johnson & Johnson subsidiary announced Nov. 28